Multimodality therapy improves survival in elderly patients with locally advanced non-small cell lung cancer—A retrospective analysis

2012 ◽  
Vol 3 (2) ◽  
pp. 104-110 ◽  
Author(s):  
Harshita R. Paripati ◽  
Nina J. Karlin ◽  
Steven E. Schild ◽  
Sujay A. Vora ◽  
Amylou C. Dueck ◽  
...  
2012 ◽  
Vol 08 (01) ◽  
pp. 24 ◽  
Author(s):  
Christine Collen ◽  
Denis Schallier ◽  
Mark De Ridder ◽  
◽  
◽  
...  

Clinicians are faced with the challenge of treating increasing numbers of elderly patients with locally advanced non-small cell lung cancer (LA-NSCLC) and co-morbid conditions. The benefit of combined chemoradiation in the younger patient using the concurrent modality compared with the sequential administration of both modalities has been established in several randomised trials and recent meta-analyses. Because of the underrepresentation of elderly patients in clinical trials on concurrent chemoradiation (CCRT) in LA-NSCLC, treatment guidelines for this age group are not well established. The objective of this report is to summarise the data on efficacy and toxicity of CCRT in the elderly.


2017 ◽  
Vol 12 (1) ◽  
pp. S857-S858
Author(s):  
Ana Linhas ◽  
Margarida Dias ◽  
Sérgio Campainha ◽  
Sara Conde ◽  
Ana Barroso

Haigan ◽  
2009 ◽  
Vol 49 (2) ◽  
pp. 162-166
Author(s):  
Kazuhito Funai ◽  
Kazuya Takamochi ◽  
Takahiro Mochizuki ◽  
Shigeru Momiki ◽  
Kazuya Suzuki

Sign in / Sign up

Export Citation Format

Share Document